Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer’s disease following chronic donepezil treatment

[1] Andreasen N(1999)Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea Dementia Project Neuroepidemiology 18 144-155

[2] Blennow K(2005)Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer’s disease J Neurol Neurosurg Psychiatry 76 315-319

[3] Sjodin C(1988)Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay J Neurochem 51 1227-1231

[4] Winblad B(2002)Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months Neurology 59 563-572

[5] Svardsudd K(2004)Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer’s disease patients J Neurochem 88 1102-1113

[6] Bohnen NI(2001)Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer’s disease Neurosci Lett 300 157-160

[7] Kaufer DI(1961)A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 88-95

[8] Hendrickson R(1982)Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies Proc Natl Acad Sci USA 79 1078-1082

[9] Ivanco LS(1975)“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189-198

[10] Lopresti BJ(2000)Cholinesterase inhibitors stabilize Alzheimer disease Neurochem Res 25 1185-1190

[1] Andreasen N(1999)Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea Dementia Project Neuroepidemiology 18 144-155

[2] Blennow K(2005)Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer’s disease J Neurol Neurosurg Psychiatry 76 315-319

[3] Sjodin C(1988)Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay J Neurochem 51 1227-1231

[4] Winblad B(2002)Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months Neurology 59 563-572

[5] Svardsudd K(2004)Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer’s disease patients J Neurochem 88 1102-1113

[6] Bohnen NI(2001)Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer’s disease Neurosci Lett 300 157-160

[7] Kaufer DI(1961)A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 88-95

[8] Hendrickson R(1982)Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies Proc Natl Acad Sci USA 79 1078-1082

[9] Ivanco LS(1975)“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189-198

[10] Lopresti BJ(2000)Cholinesterase inhibitors stabilize Alzheimer disease Neurochem Res 25 1185-1190